| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/09/2000 | EP0978561A1 Antisense oligonucleotides for the inhibition of VEGF expression |
| 02/09/2000 | EP0978515A2 1-(substituted phenyl)-4-biphenylmethyl-imidazol-2-one derivatives, their preparation and their use as angiotensin II antagonists |
| 02/09/2000 | EP0978284A1 Endothelin antagonist |
| 02/09/2000 | EP0977892A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes |
| 02/09/2000 | EP0977880A2 Materials and methods for treatment of retinal diseases |
| 02/09/2000 | EP0977879A2 Eukaryotic gene expression cassette and uses thereof |
| 02/09/2000 | EP0977854A2 Truncated vegf-related proteins |
| 02/09/2000 | EP0977850A1 Edg-1-like receptor |
| 02/09/2000 | EP0977841A2 Materials and methods for ribozyme treatment of retinal diseases |
| 02/09/2000 | EP0977773A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/09/2000 | EP0977772A1 SELECTIVE FACTOR Xa INHIBITORS |
| 02/09/2000 | EP0977756A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 02/09/2000 | EP0977753A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension |
| 02/09/2000 | EP0977751A1 Somatostatin agonists |
| 02/09/2000 | EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977741A1 Substituted phenyl derivatives, their preparation and use |
| 02/09/2000 | EP0977735A1 Vitronectin receptor antagonists |
| 02/09/2000 | EP0977593A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents |
| 02/09/2000 | EP0977578A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 02/09/2000 | EP0977565A1 Pharmaceutical composition |
| 02/09/2000 | EP0822934B1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
| 02/09/2000 | EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 02/09/2000 | CN1244196A 3-amino-1,2-benzoisoxazole derivatives, process for preparation,a nd use thereof |
| 02/09/2000 | CN1244124A Amorphous benzothiophenes, methods of preparation, and methods of use |
| 02/09/2000 | CN1243827A Preparation of heterocyclic amide derivative with specific physical status |
| 02/09/2000 | CN1243826A Antihypertensive and anticancer compound, its preparing process and its application in medicine |
| 02/09/2000 | CN1243749A Inhibitor |
| 02/09/2000 | CN1243746A Oral liquid for treating piles |
| 02/09/2000 | CN1243740A Quickly-acting medicine 'Jiuxinhuansheng Liquid' for treating acute heart diseases |
| 02/09/2000 | CN1243715A Medicine for treating piles and its preparing process |
| 02/09/2000 | CN1049116C Process for treating cardiovascular hypertrophy and hyperplasia |
| 02/08/2000 | US6022978 Benzimidazole derivatives |
| 02/08/2000 | US6022901 Administration of resveratrol to prevent or treat restenosis following coronary intervention |
| 02/08/2000 | US6022900 Preventing and ameliorating cachexia; treating whole body nitrogen loss associated with catabolic illness by inhibiting synthesis of urea from plasma arginine |
| 02/08/2000 | US6022899 Effective inhibitors of the cellular sodium proton antiporter |
| 02/08/2000 | US6022886 Endothelin receptor antagonists |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022883 Heterocyclyloxybenzoylguanidines |
| 02/08/2000 | US6022850 Use of hemoglobin in the treatment of stroke |
| 02/08/2000 | CA2014467C 3-substituted-2-oxindole derivatives |
| 02/08/2000 | CA2006387C Xanthine derivatives with adenosine-antagonistic activity |
| 02/03/2000 | WO2000005388A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | WO2000005375A1 Gbs toxin receptor |
| 02/03/2000 | WO2000005369A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000005361A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 02/03/2000 | WO2000005270A1 Biocompatible polymers, preparation method and compositions containing same |
| 02/03/2000 | WO2000005265A2 Anti-crr2 antibodies and methods of use therefor |
| 02/03/2000 | WO2000005260A1 Peptide analogues of pacap |
| 02/03/2000 | WO2000005259A1 Secreted cysteine rich protein-6 (scrp-6) |
| 02/03/2000 | WO2000005247A1 Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline |
| 02/03/2000 | WO2000005245A2 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | WO2000005244A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 02/03/2000 | WO2000005225A1 Biphenyl derivatives |
| 02/03/2000 | WO2000005224A2 Heterocyclic derivatives and their use as integrin inhibitor |
| 02/03/2000 | WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors |
| 02/03/2000 | WO2000005217A1 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 02/03/2000 | WO2000005216A1 Il-8 receptor antagonists |
| 02/03/2000 | WO2000005210A1 N,n-substituted cyclic amine derivatives |
| 02/03/2000 | WO2000005207A1 Substituted phenylamidines with antithrombotic action |
| 02/03/2000 | WO2000005201A1 N-benzocycloalkyl-amide derivatives and their use as medicaments |
| 02/03/2000 | WO2000004923A1 Scrp-5: secreted cysteine rich protein-5 |
| 02/03/2000 | WO2000004902A1 Stabilized carvedilol injection solution |
| 02/03/2000 | WO2000004892A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 02/03/2000 | WO2000004890A1 Use of glucose uptake enhancer for reducing apoptosis |
| 02/03/2000 | WO2000004889A1 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 02/03/2000 | WO2000004886A1 Formulations for the transdermal administration of fenoldopam |
| 02/03/2000 | WO2000004868A2 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | WO2000004862A2 Bioenhanced formulations comprising eprosartan in oral solid dosage form |
| 02/03/2000 | WO1999065922A3 Prenyl transferase inhibitors |
| 02/03/2000 | WO1999063936A3 Novel therapeutic agents that modulate endothelin receptors |
| 02/03/2000 | WO1999063933A3 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 02/03/2000 | WO1999061444A3 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 02/03/2000 | WO1999061097A3 Alpha emitting constructs and uses thereof |
| 02/03/2000 | WO1999059620A9 Angiostatin receptor |
| 02/03/2000 | WO1998055483A9 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 02/03/2000 | DE19834714A1 Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 2,3,3a, 4,9,9a-hexahydro-8-hydroxy-1H-ben [f] indoles, to processes for their preparation and their use as medicaments |
| 02/03/2000 | DE19834713A1 Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New phenylethylamine derivatives, processes for their preparation and their use as medicaments |
| 02/03/2000 | DE19834047A1 Substituierte Pyrazolderivate Substituted pyrazole derivatives |
| 02/03/2000 | DE19834045A1 (4-Amino-5-ethylpyrimidin-2-yl)-1-(2-fluorbenzyl)-1H-pyrazolo[3,4-b]pyridin (4-amino-5-ethylpyrimidine-2-yl) -1- (2-fluorobenzyl) -1H-pyrazolo [3,4-b] pyridine |
| 02/03/2000 | DE19834044A1 Neue substituierte Pyrazolderivate New substituted pyrazole derivatives |
| 02/03/2000 | DE19831382A1 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung Human m¶3¶G-cap-specific nuclear import receptor protein with a new domain tree, its preparation and use |
| 02/03/2000 | CA2338741A1 Il-8 receptor antagonists |
| 02/03/2000 | CA2338524A1 Inhibitors of urokinase and blood vessel formation |
| 02/03/2000 | CA2338305A1 Imidazole compounds |
| 02/03/2000 | CA2338216A1 Use of glucose uptake enhancer for reducing post-ischemic injury of the heart |
| 02/03/2000 | CA2338211A1 Use of glucose uptake enhancer for reducing apoptosis |
| 02/03/2000 | CA2338209A1 Biphenyl derivatives |
| 02/03/2000 | CA2338198A1 N-benzocycloalkyl-amide derivatives and their use as medicaments |
| 02/03/2000 | CA2337941A1 N,n-substituted cyclic amine compounds |
| 02/03/2000 | CA2337756A1 Libraries of polyhydroxamates and their analogs |
| 02/03/2000 | CA2337413A1 Substituted phenylamidines,pharmaceutical compositions containing these compounds and processes for preparing them |
| 02/03/2000 | CA2336250A1 Anti-ccr2 antibodies and methods of use therefor |
| 02/03/2000 | CA2335646A1 Genes of the dead box protein family, their expression products and use |
| 02/03/2000 | CA2335345A1 Human calcium regulatory proteins |
| 02/03/2000 | CA2335341A1 Peptide analogues of pacap |
| 02/03/2000 | CA2335326A1 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 02/03/2000 | CA2335062A1 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |